Shibao Li

6PUBLICATIONS
8CO-AUTHORS
Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 08, 2026
Dual Marker Co-Expressed Exosome-Based Liquid Biopsy Electrochemical Assay for Enhanced-Accuracy Diagnosis of Prostate Cancer.

|Apr 26, 2026
3C suppresses PINK1-mediated mitophagy and contributes to coxsackievirus B3 replication.

|Jul 21, 2025
Exploratory phase II trial of an anti-PD-1 antibody camrelizumab combined with a VEGFR-2 inhibitor apatinib and chemotherapy as a neoadjuvant therapy for triple-negative breast cancer (NeoPanDa03): efficacy, safety and biomarker analysis.

Xiaoxiao Liu, Chunying Zhuang, Lei Liu

|Oct 14, 2024
CypA/TAF15/STAT5A/miR-514a-3p feedback loop drives ovarian cancer metastasis.

Ying Li, Huiwen Yang, An Li

|Jan 18, 2023
Increased endogenous PKG I activity attenuates EGF-induced proliferation and migration of epithelial ovarian cancer via the MAPK/ERK pathway.

Ting Lan, Ying Li, Yue Wang

|May 13, 2022
ADAM10-cleaved ephrin-A5 contributes to prostate cancer metastasis.

Chenchen Cai, Miaomiao Zhang, Lei Liu

Pageof 1

Frequent Collaborators

1 joint publications

Zhong-Cheng Wang

1 joint publications

Lan Luo

1 joint publications

Lei Liu

1 joint publications

Lingyu Zeng